2/27
12:56 pm
abt
Who Is Winning Continuous Hormone Monitoring And What Comes Next [Forbes]
Low
Report
Who Is Winning Continuous Hormone Monitoring And What Comes Next [Forbes]
2/26
10:20 pm
abt
?????????????2032????631?2,600??????????????6%??? [CNET News]
Low
Report
?????????????2032????631?2,600??????????????6%??? [CNET News]
2/26
08:13 am
abt
[Latest] Global Laboratory Informatics Market Size/Share Worth USD 8.21 Billion by 2035 at a 5.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! Finance]
Low
Report
[Latest] Global Laboratory Informatics Market Size/Share Worth USD 8.21 Billion by 2035 at a 5.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! Finance]
2/25
12:35 pm
abt
Is Abbott Laboratories Stock Underperforming the Nasdaq? [Yahoo! Finance]
Low
Report
Is Abbott Laboratories Stock Underperforming the Nasdaq? [Yahoo! Finance]
2/25
07:36 am
abt
Medtronic's diabetes business MiniMed looks for $784m in US IPO [Yahoo! Finance]
Low
Report
Medtronic's diabetes business MiniMed looks for $784m in US IPO [Yahoo! Finance]
2/24
07:02 am
abt
Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics [Yahoo! Finance]
Low
Report
Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 Players - Sysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics [Yahoo! Finance]
2/23
03:57 pm
abt
Abbott Laboratories (ABT) Likely to Benefit From Nutrition Segment Recovery [Yahoo! Finance]
Neutral
Report
Abbott Laboratories (ABT) Likely to Benefit From Nutrition Segment Recovery [Yahoo! Finance]
2/23
03:32 pm
abt
Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich [Yahoo! Finance]
Low
Report
Abbott Labs: A Boring Dividend Machine That Could Quietly Make You Rich [Yahoo! Finance]
2/23
04:22 am
abt
Health and Wellness Industry Report 2026-2035: A $10.35+ Trillion Market by 2030 Featuring Major Players Such as with Abbott Laboratories, L'Oreal, Nestle, General Mills, Omron, Philips, J&J [Yahoo! Finance]
Medium
Report
Health and Wellness Industry Report 2026-2035: A $10.35+ Trillion Market by 2030 Featuring Major Players Such as with Abbott Laboratories, L'Oreal, Nestle, General Mills, Omron, Philips, J&J [Yahoo! Finance]
2/20
03:31 pm
abt
Abbott Laboratories (ABT) Announces Positive Results for Amulet 360 Left Atrial Appendage (LAA) Occlude [Yahoo! Finance]
Low
Report
Abbott Laboratories (ABT) Announces Positive Results for Amulet 360 Left Atrial Appendage (LAA) Occlude [Yahoo! Finance]
2/20
11:38 am
abt
Abbott declares 409th consecutive quarterly dividend
Low
Report
Abbott declares 409th consecutive quarterly dividend
2/20
10:00 am
abt
????????????????:???????????????2026 [CNET News]
Low
Report
????????????????:???????????????2026 [CNET News]
2/20
04:56 am
abt
Weight Management Supplements Market Report 2026: A $15+ Billion Market by 2030 Featuring Leading Players - Nestle, Abbott Laboratories, GSK, Glanbia, Herbalife Nutrition, and Amway - Forecast to 2035 [Yahoo! Finance]
Low
Report
Weight Management Supplements Market Report 2026: A $15+ Billion Market by 2030 Featuring Leading Players - Nestle, Abbott Laboratories, GSK, Glanbia, Herbalife Nutrition, and Amway - Forecast to 2035 [Yahoo! Finance]
2/18
07:10 pm
abt
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
Low
Report
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It [Yahoo! Finance]
2/18
09:29 am
abt
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at BTIG Research from $145.00 to $140.00. They now have a "buy" rating on the stock.
Low
Report
Abbott Laboratories (NYSE:ABT) had its price target lowered by analysts at BTIG Research from $145.00 to $140.00. They now have a "buy" rating on the stock.
2/17
08:10 pm
abt
?????????????: 2032????748?5,090????????CAGR 7% [CNET News]
Low
Report
?????????????: 2032????748?5,090????????CAGR 7% [CNET News]
2/15
06:13 am
abt
Could The Market Be Wrong About Abbott Laboratories (NYSE:ABT) Given Its Attractive Financial Prospects? [Yahoo! Finance]
Low
Report
Could The Market Be Wrong About Abbott Laboratories (NYSE:ABT) Given Its Attractive Financial Prospects? [Yahoo! Finance]
2/13
06:08 pm
abt
Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio [Yahoo! Finance]
Low
Report
Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio [Yahoo! Finance]
2/12
02:23 pm
abt
Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next? [Yahoo! Finance]
Low
Report
Abbott Labs Just Extended Its Dividend Aristocrat Status: What Comes Next? [Yahoo! Finance]
2/12
06:54 am
abt
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever [Yahoo! Finance]
Low
Report
Abbott Labs: The Healthcare Dividend Stock I'd Happily Hold Forever [Yahoo! Finance]
2/11
06:26 am
abt
Calculating The Fair Value Of Abbott Laboratories (NYSE:ABT) [Yahoo! Finance]
Low
Report
Calculating The Fair Value Of Abbott Laboratories (NYSE:ABT) [Yahoo! Finance]
2/9
06:42 am
abt
Senators' stock trades directly overlapped with their committee work, CNN analysis finds [CNN]
Low
Report
Senators' stock trades directly overlapped with their committee work, CNN analysis finds [CNN]
2/9
06:05 am
abt
Senators' stock trades directly overlapped with their committee work, CNN analysis finds [CNN]
Low
Report
Senators' stock trades directly overlapped with their committee work, CNN analysis finds [CNN]
2/8
04:37 am
abt
Abbott Laboratories (ABT): Short-Term Headwinds, Strategic Pipeline Strength, and UBS Buy Rating [Yahoo! Finance]
Low
Report
Abbott Laboratories (ABT): Short-Term Headwinds, Strategic Pipeline Strength, and UBS Buy Rating [Yahoo! Finance]
2/6
08:00 am
abt
Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation
Low
Report
Late-breaking data presentations showcase the safety and efficacy of Abbott's ablation catheters to treat people with atrial fibrillation